Related Experiment Video
Updated: Jun 13, 2025

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Dyspnea in Parkinson's disease
Suyash Jain1, Shruti Patel1, Kenneth Nugent2
1School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Dyspnea, or shortness of breath, is common in Parkinson's disease (PD). Research suggests both central respiratory control issues and peripheral breathing problems contribute to this debilitating symptom in PD patients.
Area of Science:
- Neurology
- Respiratory Medicine
- Pulmonary Function
Background:
- Dyspnea is a significant non-motor symptom in Parkinson's disease (PD) affecting patient quality of life.
- Understanding the causes of dyspnea in PD is challenging due to difficulties distinguishing central respiratory control issues from peripheral respiratory muscle dysfunction and chest wall rigidity.
Purpose of the Study:
- To review and synthesize existing literature on respiratory dysfunction and dyspnea in Parkinson's disease.
- To identify potential mechanisms contributing to dyspnea in PD patients.
Main Methods:
- A comprehensive literature review of observational studies on respiratory dysfunction and dyspnea in PD.
- Searched PubMed database, including studies with PD patients without other neurological disorders and excluding case studies.
- Extracted data on study size, disease duration, control groups, and respiratory defects.
Main Results:
- 23 unique publications on pulmonary function in PD were identified.
- Restrictive lung defects are prevalent in PD, found in up to 85% of patients in some studies.
- Levodopa's effect on pulmonary function varies, and research on central respiratory center involvement in PD dyspnea is limited.
Conclusions:
- Potential mechanisms for dyspnea in PD include central respiratory dysfunction, peripheral abnormalities, impaired respiratory sensation, and medication effects.
- Further research is needed on specific brainstem regions, chemoreceptor pathology, respiratory load perception, and medication impacts on pulmonary function in PD.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Respiratory Volumes and Capacities I
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Acute Respiratory Failure-IV
Hyperpnea and Hyperventilation

